coxient filmuhúðuð tafla 90 mg
zentiva k.s.* - etoricoxibum inn - filmuhúðuð tafla - 90 mg
rizatriptan sumar pharma (rizatriptan ratiopharm) munndreifitafla 10 mg
alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 10 mg
solifenacin alvogen 10 mg filmuhúðuð tafla (solifenacin portfarma) filmuhúðuð tafla 10 mg
alvogen ehf. - solifenacinum súkkínat - filmuhúðuð tafla - 10 mg
ibuprofen zentiva filmuhúðuð tafla 600 mg
zentiva k.s.* - ibuprofenum inn - filmuhúðuð tafla - 600 mg
ibetin filmuhúðuð tafla 400 mg
zentiva k.s.* - ibuprofenum inn - filmuhúðuð tafla - 400 mg
ibuprofen zentiva filmuhúðuð tafla 400 mg
zentiva k.s.* - ibuprofenum inn - filmuhúðuð tafla - 400 mg
mepsevii
ultragenyx germany gmbh - vestronidase alfa - mucopolysaccharidosis vii - ensím - mepsevii er ætlað fyrir meðferð ekki taugakerfi af mucopolysaccharidosis vii (Þingmenn vii; lúmski heilkenni).
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - Æxlishemjandi lyf - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
evkeeza
ultragenyx germany gmbh - evinacumab - kólesterólhækkun - lipid breytandi lyf - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - Æxlishemjandi lyf - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.